# Clonal Deletion on Living-Relative Donor Kidney Transplantation

> **NCT01408797** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Fuzhou General Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Renal Transplantation
- Uremia

## Interventions

- **PROCEDURE:** donor specific transfusion
- **DRUG:** MMF, Bortezomib
- **PROCEDURE:** drugs added according to the immuno condition of the recipients

## Key facts

- **NCT ID:** NCT01408797
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408797, "Clonal Deletion on Living-Relative Donor Kidney Transplantation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01408797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*